Literature DB >> 10096267

Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174.

J B McCrea1, A Cribb, T Rushmore, B Osborne, L Gillen, M W Lo, S Waldman, T Bjornsson, S Spielberg, M R Goldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10096267     DOI： 10.1016/S0009-9236(99)70114-1

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  14 in total

1.  Pharmacokinetics of Losartan and its Active Metabolite EXP3174 in Healthy Iranian Subjects.

Authors:  Hossein Amini; Abolhassan Ahmadiani; Maryam Moazenzadeh
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 2.  Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.

Authors:  Carl J Fichtenbaum; John G Gerber
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Cytochrome P450 2C9-CYP2C9.

Authors:  Derek Van Booven; Sharon Marsh; Howard McLeod; Michelle Whirl Carrillo; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-04       Impact factor: 2.089

4.  Linking pharmacovigilance with pharmacogenetics.

Authors:  David W J Clark; Emma Donnelly; David M Coulter; Rebecca L Roberts; Martin A Kennedy
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 5.  Clinical relevance of genetic polymorphisms in the human CYP2C subfamily.

Authors:  J A Goldstein
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of losartan.

Authors:  Domenic A Sica; Todd W B Gehr; Siddhartha Ghosh
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

7.  Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers.

Authors:  Yang Han; Dong Guo; Yao Chen; Yu Chen; Zhi-Rong Tan; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2009-02-17       Impact factor: 2.953

8.  Clinical pharmacology of the angiotensin receptor antagonists.

Authors:  D A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Jan-Feb       Impact factor: 3.738

Review 9.  Pharmacogenetics of warfarin elimination and its clinical implications.

Authors:  H Takahashi; H Echizen
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

10.  Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition.

Authors:  Nicholas E Thomford; Kevin Dzobo; Denis Chopera; Ambroise Wonkam; Michelle Skelton; Dee Blackhurst; Shadreck Chirikure; Collet Dandara
Journal:  Pharmaceuticals (Basel)       Date:  2015-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.